BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 22743837)

  • 1. Appropriate surveillance for late complications in patients in remission from Hodgkin lymphoma.
    Darrington DL; Vose JM
    Curr Hematol Malig Rep; 2012 Sep; 7(3):200-7. PubMed ID: 22743837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late complications after treatment for Hodgkin lymphoma.
    Ng AK
    Curr Hematol Malig Rep; 2008 Jul; 3(3):119-25. PubMed ID: 20425456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term complications in Hodgkin's lymphoma survivors.
    Kilickap S; Barista I; Ulger S; Celik I; Selek U; Güllü I; Yildiz F; Kars A; Ozisik Y; Tekuzman G
    Tumori; 2012; 98(5):601-6. PubMed ID: 23235755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the risk of therapy-associated complications in survivors of Hodgkin lymphoma.
    Travis LB
    Hematology Am Soc Hematol Educ Program; 2007; ():192-6. PubMed ID: 18024629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Best practice & research clinical haematology: Screening for breast cancer in hodgkin lymphoma survivors.
    Wong SM
    Best Pract Res Clin Haematol; 2023 Dec; 36(4):101525. PubMed ID: 38092481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current overview and special considerations for second breast cancer in Hodgkin lymphoma survivors.
    Bakkach J; Pellegrino B; Elghazawy H; Novosad O; Agrawal S; Bennani Mechita M
    Crit Rev Oncol Hematol; 2021 Jan; 157():103175. PubMed ID: 33321295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of solid subsequent malignant neoplasms after childhood Hodgkin lymphoma-Identification of high-risk populations to guide surveillance: A report from the Late Effects Study Group.
    Holmqvist AS; Chen Y; Berano Teh J; Sun C; Birch JM; van den Bos C; Diller LR; Dilley K; Ginsberg J; Martin LT; Nagarajan R; Nathan PC; Neglia JP; Terenziani M; Tishler D; Meadows AT; Robison LL; Oberlin O; Bhatia S
    Cancer; 2019 Apr; 125(8):1373-1383. PubMed ID: 30556153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late mortality, secondary malignancy and hospitalisation in teenage and young adult survivors of Hodgkin lymphoma: report of the Childhood/Adolescent/Young Adult Cancer Survivors Research Program and the BC Cancer Agency Centre for Lymphoid Cancer.
    Bhuller KS; Zhang Y; Li D; Sehn LH; Goddard K; McBride ML; Rogers PC
    Br J Haematol; 2016 Mar; 172(5):757-68. PubMed ID: 26727959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. State-of-the-art issues in Hodgkin's lymphoma survivorship.
    Baxi SS; Matasar MJ
    Curr Oncol Rep; 2010 Nov; 12(6):366-73. PubMed ID: 20734173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton therapy for Hodgkin lymphoma.
    Rutenberg MS; Flampouri S; Hoppe BS
    Curr Hematol Malig Rep; 2014 Sep; 9(3):203-11. PubMed ID: 24842407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late effects of treatment for Hodgkin lymphoma.
    Friedman DL; Constine LS
    J Natl Compr Canc Netw; 2006 Mar; 4(3):249-57. PubMed ID: 16507272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in the Risks of Secondary Cancers in Patients With Hodgkin Lymphoma.
    Kumar V; Garg M; Chandra AB; Mayorga VS; Ahmed S; Ailawadhi S
    Clin Lymphoma Myeloma Leuk; 2018 Sep; 18(9):576-589.e1. PubMed ID: 29934060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term risk of second malignancy and cardiovascular disease after Hodgkin lymphoma treatment.
    van Leeuwen FE; Ng AK
    Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):323-330. PubMed ID: 27913498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hodgkin lymphoma: the follow-up of long-term survivors.
    Hodgson DC
    Hematol Oncol Clin North Am; 2008 Apr; 22(2):233-44, vi. PubMed ID: 18395147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second cancers in survivors of hodgkin lymphoma: risks and recommendations.
    Leahy Y
    Clin J Oncol Nurs; 2008 Jun; 12(3):437-42. PubMed ID: 18515242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hodgkin lymphoma: Late effects of treatment and guidelines for surveillance.
    Ng AK; van Leeuwen FE
    Semin Hematol; 2016 Jul; 53(3):209-15. PubMed ID: 27496313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening mammography for young women treated with supradiaphragmatic radiation for Hodgkin's lymphoma.
    Lee L; Pintilie M; Hodgson DC; Goss PE; Crump M
    Ann Oncol; 2008 Jan; 19(1):62-7. PubMed ID: 17878177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant chemotherapy administration and survival outcomes of lymphoma survivors with common solid tumors: a population-based study†.
    Di M; Panagiotou OA; Reagan JL; Niroula R; Olszewski AJ
    Leuk Lymphoma; 2020 Dec; 61(14):3360-3368. PubMed ID: 32915087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hodgkin's disease. Treatment sequelae and quality of life.
    Henry-Amar M
    Baillieres Clin Haematol; 1996 Sep; 9(3):595-618. PubMed ID: 8922248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late morbidity and mortality in patients with Hodgkin's lymphoma treated during adulthood.
    Matasar MJ; Ford JS; Riedel ER; Salz T; Oeffinger KC; Straus DJ
    J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25717170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.